Case Studies
Senate Panel Flags Misleading Cannabis Marketing, Backs Psychedelics Research
LOS ANGELES- The Senate Appropriations Committee released a report accompanying ...
Week In Review: Aurora Cannabis Denies Acquisition of MedLeaf Therapeutics; Canadian Cannabis Producers Expand Exports; Method Man and Zamnesia Partner to Launch Eight TICAL Cannabis Seeds in U.S. and Europe
LOS ANGELES — Welcome to the far too-exciting world of ...
Method Man and Zamnesia Partner to Launch Eight TICAL Cannabis Seeds in U.S. and Europe
LOS ANGELES- Zamnesia—a European online retailer specializing in cannabis seeds—has ...
Silo Pharma’s SP-26 Ketamine Implant Meets All Endpoints in Preclinical Fibromyalgia Study
LOS ANGELES- Silo Pharma Inc. a developmental-stage biopharmaceutical company, announced that its investigational ketamine implant, SP-26, met all primary endpoints in a preclinical study targeting fibromyalgia. The study, conducted in minipigs, assessed the implant's safety, ...
Tilray Medical Introduces Good Supply Cannabis Brand to German Market
LOS ANGELES- Tilray Medical, a division of Tilray Brands Inc has launched its Canadian cannabis brand, Good Supply, in Germany. This expansion aims to provide German medical cannabis patients with access to a range of ...
MariMed Reports Q1 2025 Financial Results
LOS ANGELES- MariMed Inc. a multi-state cannabis operator, reported its financial results for the first quarter ended March 31, 2025. Financial Overview Revenue: $38.0 million, a slight increase from $37.9 million in Q1 2024. Gross ...
Greewave Advisors Analysis: Cannabis Companies & Cash Flow – Size Matters
Over the past 6 years (2019-2024), the Tier 1 Multistate Operators (MSOs) have generated $2.3B in Cash Flow from Operations (CFO); Assuming all unpaid 280E related tax liabilities are satisfied this amount is $1.3 Billion. ...
New Mexico Takes a Landmark Step Toward Legal Psychedelic Therapy
LOS ANGELES- New Mexico just made history—again. Governor Michelle Lujan Grisham has officially signed the Medical Psilocybin Act into law, positioning New Mexico as the third U.S. state to legalize psilocybin for therapeutic use. But ...
4/20 Cannabis Price Wars: How a Cultural Milestone Became a Cautionary Tale
LOS ANGELES- Once a day to honor cannabis culture, April 20th—aka 4/20—has increasingly become a flashpoint in the cannabis industry’s struggle for survival. What began as a grassroots celebration has devolved, in many markets, into ...
Montana Legislature Approves Bill to Tighten Cannabis Product Regulations
LOS ANGELES— The Montana Legislature has passed House Bill 636, introducing new restrictions on cannabis products. The Senate approved the bill with a 37–12 vote, following the House's 84–15 approval last month. House Bill ...
Silo Pharma’s SP-26 Ketamine Implant Meets All Endpoints in Preclinical Fibromyalgia Study
LOS ANGELES- Silo Pharma Inc. a developmental-stage biopharmaceutical company, announced that its investigational ketamine implant, SP-26, met all primary endpoints in a preclinical study targeting fibromyalgia. The study, conducted in minipigs, assessed the implant's safety, ...
Tilray Medical Introduces Good Supply Cannabis Brand to German Market
LOS ANGELES- Tilray Medical, a division of Tilray Brands Inc has launched its Canadian cannabis brand, Good Supply, in Germany. This expansion aims to provide German medical cannabis patients with access to a range of ...
MariMed Reports Q1 2025 Financial Results
LOS ANGELES- MariMed Inc. a multi-state cannabis operator, reported its financial results for the first quarter ended March 31, 2025. Financial Overview Revenue: $38.0 million, a slight increase from $37.9 million in Q1 2024. Gross ...
Maryland Supreme Court Refuses to Review Injunction on Anti-Intoxicating Hemp Law
LOS ANGELES- The Maryland Supreme Court has recently opted not to review a lower court's injunction against the enforcement of the state's law aimed at banning intoxicating hemp products. This decision, as detailed in a ...
Georgia Advances Medical Cannabis Program After Legal Delays
LOS ANGELES' In a significant development for Georgia's medical cannabis sector, state regulators have resumed the licensing process, concluding a prolonged two-year legal standoff. This move, as reported by the Valdosta Daily Times, comes after ...
Algernon Pharmaceuticals Partners with Seyltx Inc.
LOS ANGELES- Algernon Pharmaceuticals Inc., a Canadian clinical stage pharmaceutical development company, has announced a significant advancement in its research program. The company has signed a Letter of Intent (LOI) with Seyltx Inc., a U.S.-based ...
Psychedelic Therapy for PTSD: Veterans Seek Healing in Mexico Amid U.S. Legal Restrictions
LOS ANGELES- A recent CBS News report has brought to light a significant trend among veterans dealing with PTSD: an increasing number are seeking psychedelic-assisted treatments in Mexico, utilizing substances currently deemed illegal by the ...
Optimi Health Obtains Key Amendment to Dealer’s Licence
LOS ANGELES- Optimi Health, a Canadian company specializing in psychedelic drug research and formulation, has achieved a significant milestone with Health Canada's approval of an amendment to its Dealer's Licence. This crucial development allows Optimi ...
Germany Amends Cannabis Legalization Bill, Balancing Reform and Regulation
BERLIN- German lawmakers have significantly revised the country's cannabis legalization bill, incorporating feedback from cannabis reform advocates and aiming for the bill's enactment in the upcoming spring. This development, as reported by Marijuana Moment, ...
Psyence Group Inc. Announces Resignation of Board Member Marvin Singer
LOS ANGELES- Psyence Group Inc a clinical-stage life science biotechnology firm at the forefront of utilizing nature-derived psilocybin for mental health and wellbeing, today announced the resignation of Mr. Marvin Singer from his role as ...
Compass Pathways Launches UK Phase of Landmark Psilocybin Study for Treatment-Resistant Depression
NEW YORK- Compass Pathways plc (Nasdaq: CMPS), a biotechnology leader dedicated to advancing mental health treatments, has announced the initiation of the UK component of its phase 3 program investigating COMP360 psilocybin treatment for treatment-resistant ...
Alabama Medical Cannabis Commission Settles Lawsuits
LOS ANGELES- The Alabama Medical Cannabis Commission (AMCC) has made significant strides this week by reaching a settlement with license applicants, a move aimed at resolving the multiple lawsuits filed against the agency. This development, ...
Swedish Researchers Use Psychedelics to Explore Brain Function and AI Development
LOS ANGELES- In a groundbreaking study at Lund University in Sweden, researchers are employing psychedelic substances, specifically acid (LSD) and ketamine, to delve into the intricate workings of the brain. This unique approach aims to ...
Minnesota Tests New Saliva-Based Roadside Cannabis Impairment Assessment
LOS ANGELES- In a groundbreaking move, Minnesota's Office of Traffic Safety (OTS) has initiated a pilot program to test a saliva-based roadside cannabis impairment test. This innovative approach is designed to enhance the state's capabilities ...
New York and Missouri’s Contrasting Cannabis Market Progress in 2023
NEW YORK- In a striking contrast of cannabis market development, New York and Missouri have reported significantly differing sales figures in 2023. New York's licensed cannabis dispensaries have achieved over $100 million in adult-use sales, ...
Cybin Inc. Secures $30 Million in Funding to Advance Psychedelic Treatment Research
NEW YORK- Toronto-based Cybin Inc., a clinical-stage biopharmaceutical company, has successfully completed a significant funding round, bolstering its commitment to revolutionize mental healthcare through the development of innovative psychedelic treatments. The company announced the closure ...
Clearmind Medicine Inc. Announces Reverse Share Split to Comply with Nasdaq Regulations
NEW YORK- Clearmind Medicine Inc., a biotech company renowned for its innovative work in developing psychedelic-derived therapeutics, has announced a strategic decision to conduct a reverse share split of its ordinary shares. This move is ...
Revive Therapeutics Advances Development of Innovative Bucillamine Formulation for Medical Emergencies
LOS ANGELES- Revive Therapeutics Ltd, a specialty life sciences company, has recently announced significant progress in the development of a new lyophilized formulation of Bucillamine, a drug initially designed for medical needs and rare disorders. ...
Oklahoma Prolongs Medical Cannabis License Moratorium to 2026 Amid Regulatory Review
LOS ANGELES- In a significant move for the state's cannabis industry, Oklahoma has decided to extend its moratorium on new medical cannabis licenses up to 2026, as reported by Tulsa World. This extension hinges on ...
New York Sets Stringent Regulations on Hemp Products, Banning Delta-8 and Other THC Variants
NEW YORK- New York's cannabis regulatory framework has reached a new milestone with the finalization of rules governing intoxicating hemp products. The state's regulators have imposed a ban on specific THC variants, including Delta-8 THC, ...
Pennsylvania Moves to Expand Medical Cannabis Retail Access, Breaking Up Potential Monopoly
NEW YORK- Pennsylvania is poised to significantly expand its medical cannabis industry, with new legislation on the horizon that could allow all of its 25 medical cannabis grower/processor licensees to also operate retail outlets. This ...
California Regulators Impose Embargo on Cannabis Products from Three Companies Over Safety Concerns
LOS ANGELES- California's Department of Cannabis Control (DCC) has taken decisive action by imposing an embargo on cannabis products from three companies, citing concerns that these products may have been "adulterated" and potentially harmful. This ...
South Dakota on the Cusp of Major Cannabis Reform with New Adult-Use Ballot Initiatives
LOS ANGELES- In a significant development for cannabis legislation, South Dakota has introduced two new adult-use cannabis legalization measures, aiming for inclusion in the 2024 general election. Both initiatives require 17,509 valid signatures from registered ...
Navigating the Green: Unraveling the Taxing Dilemma in the Cannabis Industry
LOS ANGELES- In the ever-expanding landscape of the cannabis industry, where green is not just a color but a thriving economic force, the question of taxation looms large. As states grapple with the complex task ...
Silo Pharma Secures Exclusive License for MedSpray’s Intranasal Technology for SPC-15 Drug Delivery
NERW YORK – Silo Pharma, Inc. a biopharmaceutical company at the forefront of merging traditional therapeutics with psychedelic research, announced today its new exclusive licensing agreement with Medspray Pharma BV. This agreement centers around Medspray's ...
New York Finalizes Regulations for Intoxicating Hemp Products, Banning Certain THC Variants
NEW YORK – New York's cannabis regulators have recently established definitive rules for intoxicating hemp products, introducing a series of restrictions and standards that are expected to reshape the hemp market in the state. As ...
Hawaii Attorney General Proposes Comprehensive Plan for Recreational Cannabis Legalization
LOS ANGELES– Hawaii Attorney General Anne Lopez recently unveiled a detailed proposal to legalize recreational cannabis, marking a significant step forward in the state's cannabis policy reform. This initiative comes eight months after a similar ...
Ohio Senate President Seeks Changes to Cannabis Legalization Law Amid Controversy
LOS ANGELES- In a move that is stirring debate, Ohio State Senate President Matt Huffman is spearheading a bipartisan effort to revise Ohio's recently approved cannabis legalization law, Issue 2, before its main provisions take ...
